Wordt geladen...
Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases
BACKGROUND: Very little is known about the impact of the wash-out period on the pharmacokinetics of a second-line biologic. OBJECTIVE: The objective of this article is to explore the impact of two different wash-out periods on the pharmacokinetics of vedolizumab and infliximab. METHODS: Patients swi...
Bewaard in:
| Gepubliceerd in: | United European Gastroenterol J |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publications
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6620879/ https://ncbi.nlm.nih.gov/pubmed/31316779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619841538 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|